0000919574-17-001876.txt : 20170214 0000919574-17-001876.hdr.sgml : 20170214 20170214121639 ACCESSION NUMBER: 0000919574-17-001876 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170214 DATE AS OF CHANGE: 20170214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: IMPAX LABORATORIES INC CENTRAL INDEX KEY: 0001003642 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 650403311 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-48867 FILM NUMBER: 17605672 BUSINESS ADDRESS: STREET 1: 30831 HUNTWOOD AVENUE CITY: HAYWARD STATE: CA ZIP: 94544 BUSINESS PHONE: 510-240-6000 MAIL ADDRESS: STREET 1: 30831 HUNTWOOD AVENUE CITY: HAYWARD STATE: CA ZIP: 94544 FORMER COMPANY: FORMER CONFORMED NAME: GLOBAL PHARMACEUTICAL CORP \DE\ DATE OF NAME CHANGE: 19951117 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Hound Partners, LLC CENTRAL INDEX KEY: 0001353316 IRS NUMBER: 201434967 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 101 PARK AVENUE STREET 2: 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10178 BUSINESS PHONE: 2129842326 MAIL ADDRESS: STREET 1: 101 PARK AVENUE STREET 2: 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10178 SC 13G/A 1 d7413705_13g-a.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

SCHEDULE 13G
(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
 
(Amendment No. 2)

 
Impax Laboratories, Inc.
(Name of Issuer)


Class A Common Stock, $.01 Par Value Per Share
(Title of Class of Securities)
 
45256B101
(CUSIP Number)

 
December 31, 2016
(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[X]  Rule 13d-1(b)

[   ]  Rule 13d-1(c)

[_]  Rule 13d-1(d)

__________

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No.
45256B101
    
 
1.
NAME OF REPORTING PERSONS
  
 
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
  
     
 
Hound Partners, LLC
  
     
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
   
(a)  [_]
   
(b)  [X]
     
3.
SEC USE ONLY
  
     
     
     
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
  
     
 
Delaware
  
     
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
     
5.
SOLE VOTING POWER
  
     
 
0
  
     
6.
SHARED VOTING POWER
  
     
 
4,436,376
  
     
7.
SOLE DISPOSITIVE POWER
  
     
 
0
  
     
8.
SHARED DISPOSITIVE POWER
  
     
 
4,436,376
  
     
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
 
4,436,376
  
     
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
  
   
[_]
     
     
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
  
     
 
6.01%
  
     
12.  TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)   
     
  OO  

CUSIP No.
45256B101
    
 
1.
NAME OF REPORTING PERSONS
  
 
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
  
     
 
Hound Performance, LLC
  
     
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
   
(a)  [_]
   
(b)  [X]
     
3.
SEC USE ONLY
  
     
     
     
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
  
     
 
Delaware
  
     
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
     
5.
SOLE VOTING POWER
  
     
 
0
  
     
6.
SHARED VOTING POWER
  
     
 
4,309,611
  
     
7.
SOLE DISPOSITIVE POWER
  
     
 
0
  
     
8.
SHARED DISPOSITIVE POWER
  
     
 
4,309,611
  
     
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
 
4,309,611
  
     
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
  
   
[_]
     
     
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
  
     
 
5.83%
  
     
12.  TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)   
     
  OO   

CUSIP No.
45256B101
    
 
1.
NAME OF REPORTING PERSONS
  
 
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
  
     
 
Jonathan Auerbach*
  
     
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
   
(a)  [_]
   
(b)  [X]
     
3.
SEC USE ONLY
  
     
     
     
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
  
     
 
United States
  
     
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
     
5.
SOLE VOTING POWER
  
     
 
0
  
     
6.
SHARED VOTING POWER
  
     
 
4,436,376
  
     
7.
SOLE DISPOSITIVE POWER
  
     
 
0
  
     
8.
SHARED DISPOSITIVE POWER
  
     
 
4,436,376
  
     
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
 
4,436,376
  
     
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
  
   
[_]
     
     
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
  
     
 
6.01%
  
     
12.  TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)   
     
  IN   

*
The initial Schedule 13G, filed on December 9, 2105, incorrectly listed Matthew Gilman as the managing member of Hound Partners, LLC and Hound Performance, LLC and as a beneficial owner of the issuer.  This amendment corrects the initial filing by listing Johnathan Auerbach as the managing member of Hound Partners, LLC and Hound Performance, LLC and as a beneficial owner of the issuer.
 
 
CUSIP No.
45256B101
    

Item 1.
(a).
Name of Issuer:
  
       
   
Impax Laboratories, Inc.
  

 
(b).
Address of issuer's principal executive offices:
  
       
   
The Proscenium
30831 Huntwood Avenue
 Hayward, California 94544
  
 
Item 2.
(a) – (c)
Hound Partners, LLC
  
   
101 Park Avenue, 48th Floor
New York, NY 10178
  
       
   
Hound Performance, LLC
101 Park Avenue, 48th Floor
New York, NY 10178
  
       
   
Jonathan Auerbach
101 Park Avenue, 48th Floor
New York, NY 10178

 
(d).
Title of class of securities:
  
       
   
Class A Common Stock, $.01 par value per share

 
(e).
CUSIP No.:
  
       
   
45256B101
 
Item 3.
  If This Statement is filed pursuant to §§.240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a
 
 
(a)
[_]
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

 
(b)
[_]
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

 
(c)
[_]
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

 
(d)
[_]
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

 
(e)
[X]
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

 
(f)
[_]
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

 
(g)
[_]
A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

 
(h)
[_]
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813);

 
(i)
[_]
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

 
(j)
[_]
A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
 
 
Item 4.
Ownership.

 
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 
(a)
Amount beneficially owned:
     
   
Hound Partners, LLC
4,436,376 shares
     
   
Hound Performance, LLC
4,309,611 shares
     
   
Jonathan Auerbach
4,436,376 shares

 
(b)
Percent of class:
     
   
Hound Partners, LLC
6.01%
     
   
Hound Performance, LLC
5.83%
     
   
Jonathan Auerbach
6.01%

 
(c)
Number of shares as to which the person has:
         
   
(i)
Sole power to vote or to direct the vote
  
       
   
Hound Partners, LLC
0
     
   
Hound Performance, LLC
0
     
   
Jonathan Auerbach
0
       
   
(ii)
Shared power to vote or to direct the vote
  
       
   
Hound Partners, LLC
4,436,376 shares
     
   
Hound Performance, LLC
4,309,611 shares
     
   
Jonathan Auerbach
4,436,376 shares
       
   
(iii)
Sole power to dispose or to direct the disposition of
    
       
   
Hound Partners, LLC
0
     
   
Hound Performance, LLC
0
     
   
Jonathan Auerbach
0
       
   
(iv)
Shared power to dispose or to direct the disposition of
  
       
   
Hound Partners, LLC
4,436,376 shares
     
   
Hound Performance, LLC
4,309,611 shares
     
   
Jonathan Auerbach
4,436,376 shares
 
 
Item 5.
Ownership of Five Percent or Less of a Class.

 
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [_].
 
 
N/A

Item 6.
Ownership of More Than Five Percent on Behalf of Another Person.

 
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than five percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
 
N/A
 
 
Item 7.
 
 
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
 
 
If a parent holding company or Control person has filed this schedule, pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company or control person has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
 
N/A
   
Item 8.
Identification and Classification of Members of the Group.
   
 
If a group has filed this schedule pursuant to ss.240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to ss.240.13d-1(c) or ss.240.13d-1(d), attach an exhibit stating the identity of each member of the group.
 
N/A

Item 9.
Notice of Dissolution of Group.

 
Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5.
 
N/A
   

Item 10.
Certification.

 
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect.



SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


   
February 14, 2017
   
(Date)
     
     
 
HOUND PARTNERS, LLC (1)
     
 
By:
/s/ Courtney Lewis
 
Courtney Lewis, Authorized Person
     
     
 
HOUND PERFORMANCE, LLC (1)
     
 
By:
/s/ Courtney Lewis
 
Courtney Lewis, Authorized Person
     
     
 
/s/ Jonathan Auerbach (1)
 
JONATHAN AUERBACH
     
(1) The Reporting Persons disclaim beneficial ownership except to the extent of their pecuniary interest therein.


Exhibit A


AGREEMENT


The undersigned agree that this Schedule 13G Amendment number 2 dated February 14, 2017 relating to the Class A Common Stock, $.01 par value per share of Impax Laboratories, Inc. shall be filed on behalf of the undersigned.


 
HOUND PARTNERS, LLC
     
 
By:
/s/ Courtney Lewis
 
Courtney Lewis, Authorized Person
     
   
 
HOUND PERFORMANCE, LLC
     
 
By:
/s/ Courtney Lewis
 
Courtney Lewis, Authorized Person
     
     
 
/s/ Jonathan Auerbach
 
JONATHAN AUERBACH
 
Exhibit B

Hound Partners, LLC is the relevant entity for which Jonathan Auerbach may be considered a control person.